1. Home
  2. SILO vs MITQ Comparison

SILO vs MITQ Comparison

Compare SILO & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silo Pharma Inc.

SILO

Silo Pharma Inc.

HOLD

Current Price

$1.80

Market Cap

3.1M

ML Signal

HOLD

Logo Moving iMage Technologies Inc.

MITQ

Moving iMage Technologies Inc.

HOLD

Current Price

$0.62

Market Cap

6.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SILO
MITQ
Founded
2010
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Telecommunications Equipment
Sector
Consumer Discretionary
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
3.1M
6.2M
IPO Year
2011
2019

Fundamental Metrics

Financial Performance
Metric
SILO
MITQ
Price
$1.80
$0.62
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
34.4K
★ 91.0K
Earning Date
05-13-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 57.98
N/A
EPS
N/A
★ N/A
Revenue
$72,102.00
★ $20,139,000.00
Revenue This Year
$1.86
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$58.00
Revenue Growth
★ N/A
N/A
52 Week Low
$0.22
$0.42
52 Week High
$7.95
$1.12

Technical Indicators

Market Signals
Indicator
SILO
MITQ
Relative Strength Index (RSI) 26.74 54.00
Support Level $1.63 $0.62
Resistance Level $4.80 $0.66
Average True Range (ATR) 0.17 0.05
MACD 0.04 0.00
Stochastic Oscillator 22.37 47.08

Price Performance

Historical Comparison
SILO
MITQ

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.

About MITQ Moving iMage Technologies Inc.

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.

Share on Social Networks: